Allos Therapeutics Inc (ALTH)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre Partager sur 𝕏

Cours de l'action
Code mnémonique : ALTH Marché : NSQ


Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités
• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette
90 derniers jours
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
Date de notification Date de transaction A/V Type de transaction Initié et/ou titre Nb. d'actions
Prix
Valeur 		Nombre d'actions Prix Valeur totale Détails
2012-09-06 2012-09-05 A Achat

SPECTRUM PHARMACEUTICALS INC

Large shareholder
130 854 840 +100.0%
1,82
238 155 809 USD 		130 854 840 +100.0% 1,82 238 155 809 USD
2012-03-01 2012-03-01 VP Vente planifiée

BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Dirigeant
3 025 -2.0%
1,50
4 522 USD 		3 025 -2.0% 1,50 4 522 USD
2012-03-01 2012-02-29 VP Vente planifiée

BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Dirigeant
3 031 -2.0%
1,53
4 623 USD 		3 031 -2.0% 1,53 4 623 USD
2012-02-27 2012-02-24 VP Vente planifiée

BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Dirigeant
1 469 -1.3%
1,55
2 277 USD 		1 469 -1.3% 1,55 2 277 USD
2011-02-25 2011-02-24 VP Vente planifiée

BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Dirigeant
1 469 -1.5%
3,20
4 701 USD 		1 469 -1.5% 3,20 4 701 USD
2010-05-12 2010-05-10 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
3 085 -15.3%
7,03
21 684 USD 		3 085 -15.3% 7,03 21 684 USD
2010-04-14 2010-04-12 VP Vente planifiée

Graboyes Marc H

SVP, General Counsel

Dirigeant
75 000 -56.4%
8,58
643 530 USD 		75 000 -56.4% 8,58 643 530 USD
2010-03-12 2010-03-10 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
20 000 -50.8%
7,78
155 612 USD 		20 000 -50.8% 7,78 155 612 USD
2010-03-08 2010-03-05 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
10 000 -34.1%
7,02
70 196 USD 		10 000 -34.1% 7,02 70 196 USD
2010-03-08 2010-03-04 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
11 640 -37.6%
6,98
81 301 USD 		11 640 -37.6% 6,98 81 301 USD
2010-03-03 2010-03-01 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
37 500 -26.6%
8,13
304 875 USD 		37 500 -26.6% 8,13 304 875 USD
2010-03-03 2010-03-01 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
40 000 -22.1%
8,13
325 204 USD 		40 000 -22.1% 8,13 325 204 USD
2010-02-24 2010-02-24 VP Vente planifiée

BERNS PAUL L

Chief Executive Officer

Dirigeant
7 362 -3.2%
7,57
55 766 USD 		7 362 -3.2% 7,57 55 766 USD
2010-02-24 2010-02-24 VP Vente planifiée

Graboyes Marc H

SVP, General Counsel

Dirigeant
2 349 -3.9%
7,44
17 477 USD 		2 349 -3.9% 7,44 17 477 USD
2010-02-24 2010-02-23 VP Vente planifiée

BERNS PAUL L

Chief Executive Officer

Dirigeant
4 304 -1.8%
7,51
32 331 USD 		4 304 -1.8% 7,51 32 331 USD
2010-02-24 2010-02-23 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
5 968 -4.1%
7,44
44 378 USD 		5 968 -4.1% 7,44 44 378 USD
2010-02-24 2010-02-23 VP Vente planifiée

Graboyes Marc H

SVP, General Counsel

Dirigeant
1 416 -2.3%
7,51
10 634 USD 		1 416 -2.3% 7,51 10 634 USD
2010-02-24 2010-02-23 VP Vente planifiée

BENNETT BRUCE K JR

VP, Pharmaceutical Operations

Dirigeant
1 468 -6.0%
7,51
11 025 USD 		1 468 -6.0% 7,51 11 025 USD
2010-01-11 2010-01-11 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
45 428 -8.7%
7,30
331 738 USD 		45 428 -8.7% 7,30 331 738 USD
2010-01-11 2010-01-08 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
45 429 -8.7%
7,11
322 918 USD 		45 429 -8.7% 7,11 322 918 USD
2010-01-11 2010-01-07 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
45 429 -8.7%
6,76
307 114 USD 		45 429 -8.7% 6,76 307 114 USD
2010-01-06 2010-01-06 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
45 429 -8.7%
6,78
308 163 USD 		45 429 -8.7% 6,78 308 163 USD
2010-01-06 2010-01-05 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
45 428 -8.7%
6,64
301 497 USD 		45 428 -8.7% 6,64 301 497 USD
2010-01-06 2010-01-04 VP Vente planifiée

HOFFMAN STEPHEN J

Administrateur non-exécutif
25 428 -5.1%
6,54
166 220 USD 		25 428 -5.1% 6,54 166 220 USD
2009-08-12 2009-08-10 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
85 400 -49.0%
8,13
694 302 USD 		85 400 -49.0% 8,13 694 302 USD
2009-08-12 2009-08-10 VP Vente planifiée

BERNS PAUL L

Chief Executive Officer

Dirigeant
342 000 -59.6%
8,24
2 819 311 USD 		342 000 -59.6% 8,24 2 819 311 USD
2009-08-07 2009-08-05 VP Vente planifiée

BERNS PAUL L

Chief Executive Officer

Dirigeant
8 000 -3.3%
8,14
65 150 USD 		8 000 -3.3% 8,14 65 150 USD
2009-08-05 2009-08-05 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
14 600 -14.1%
8,13
118 755 USD 		14 600 -14.1% 8,13 118 755 USD
2009-08-05 2009-08-03 VP Vente planifiée

Graboyes Marc H

VP, General Counsel

Dirigeant
50 000 -71.4%
8,00
400 000 USD 		50 000 -71.4% 8,00 400 000 USD
2009-08-05 2009-08-03 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
50 000 -36.0%
7,79
389 480 USD 		50 000 -36.0% 7,79 389 480 USD
2009-03-27 2009-03-26 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
39 500 -25.3%
7,37
291 206 USD 		39 500 -25.3% 7,37 291 206 USD
2009-03-27 2009-03-25 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
6 900 -5.6%
7,13
49 209 USD 		6 900 -5.6% 7,13 49 209 USD
2009-03-16 2009-03-16 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
3 600 -3.0%
7,13
25 674 USD 		3 600 -3.0% 7,13 25 674 USD
2009-03-16 2009-03-13 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
5 027 -41.3%
7,00
35 189 USD 		5 027 -41.3% 7,00 35 189 USD
2009-03-16 2009-03-13 VP Vente planifiée

Graboyes Marc H

VP, General Counsel

Dirigeant
5 864 -22.6%
7,00
41 048 USD 		5 864 -22.6% 7,00 41 048 USD
2009-03-16 2009-03-12 VP Vente planifiée

Clark David C

VP, Finance

Dirigeant
64 973 -90.1%
7,02
455 812 USD 		64 973 -90.1% 7,02 455 812 USD
2009-03-16 2009-03-12 VP Vente planifiée

CARUSO JAMES V

Chief Commercial Officer

Dirigeant
50 000 -30.1%
7,13
356 500 USD 		50 000 -30.1% 7,13 356 500 USD
2009-03-16 2009-03-12 VP Vente planifiée

Graboyes Marc H

VP, General Counsel

Dirigeant
69 136 -77.5%
7,02
485 010 USD 		69 136 -77.5% 7,02 485 010 USD
2009-02-06 2009-02-06 V Vente

14159 capital (GP), LLC

Large shareholder
22 -0.0%
8,26
182 USD 		22 -0.0% 8,26 182 USD
2009-02-06 2009-02-06 V Vente

14159 capital (GP), LLC

Large shareholder
24 857 -11.5%
8,17
203 176 USD 		24 857 -11.5% 8,17 203 176 USD
2009-02-06 2009-02-06 V Vente

BAKER JULIAN

Large shareholder
1 -0.0%
8,26
8 USD 		1 -0.0% 8,26 8 USD
2009-02-06 2009-02-06 V Vente

BAKER JULIAN

Large shareholder
705 -11.5%
8,17
5 763 USD 		705 -11.5% 8,17 5 763 USD
2009-02-06 2009-02-06 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
235 -0.0%
8,26
1 940 USD 		235 -0.0% 8,26 1 940 USD
2009-02-06 2009-02-06 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
263 312 -11.5%
8,17
2 152 260 USD 		263 312 -11.5% 8,17 2 152 260 USD
2009-02-06 2009-02-06 V Vente

Baker Bros. Capital (GP), LLC

Large shareholder
212 -11.5%
8,17
1 733 USD 		212 -11.5% 8,17 1 733 USD
2009-02-06 2009-02-06 V Vente

Baker / Tisch Capital (GP), LLC

Large shareholder
8 -0.0%
8,26
66 USD 		8 -0.0% 8,26 66 USD
2009-02-06 2009-02-06 V Vente

Baker / Tisch Capital (GP), LLC

Large shareholder
9 380 -11.5%
8,17
76 670 USD 		9 380 -11.5% 8,17 76 670 USD
2009-02-06 2009-02-06 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
670 -0.0%
8,26
5 532 USD 		670 -0.0% 8,26 5 532 USD
2009-02-06 2009-02-06 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
751 534 -11.5%
8,17
6 142 889 USD 		751 534 -11.5% 8,17 6 142 889 USD
2009-02-06 2009-02-05 V Vente

14159 capital (GP), LLC

Large shareholder
4 725 -2.1%
8,11
38 299 USD 		4 725 -2.1% 8,11 38 299 USD
2009-02-06 2009-02-05 V Vente

14159 capital (GP), LLC

Large shareholder
1 200 -0.5%
8,17
9 806 USD 		1 200 -0.5% 8,17 9 806 USD
2009-02-06 2009-02-05 V Vente

14159 capital (GP), LLC

Large shareholder
6 392 -2.8%
8,16
52 180 USD 		6 392 -2.8% 8,16 52 180 USD
2009-02-06 2009-02-05 V Vente

BAKER JULIAN

Large shareholder
134 -2.1%
8,11
1 086 USD 		134 -2.1% 8,11 1 086 USD
2009-02-06 2009-02-05 V Vente

BAKER JULIAN

Large shareholder
34 -0.5%
8,17
278 USD 		34 -0.5% 8,17 278 USD
2009-02-06 2009-02-05 V Vente

BAKER JULIAN

Large shareholder
181 -2.8%
8,16
1 478 USD 		181 -2.8% 8,16 1 478 USD
2009-02-06 2009-02-05 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
50 041 -2.1%
8,11
405 617 USD 		50 041 -2.1% 8,11 405 617 USD
2009-02-06 2009-02-05 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
12 713 -0.5%
8,17
103 882 USD 		12 713 -0.5% 8,17 103 882 USD
2009-02-06 2009-02-05 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
67 709 -2.8%
8,16
552 729 USD 		67 709 -2.8% 8,16 552 729 USD
2009-02-06 2009-02-05 V Vente

Baker Bros. Capital (GP), LLC

Large shareholder
40 -2.1%
8,11
324 USD 		40 -2.1% 8,11 324 USD
2009-02-06 2009-02-05 V Vente

Baker Bros. Capital (GP), LLC

Large shareholder
10 -0.5%
8,17
82 USD 		10 -0.5% 8,17 82 USD
2009-02-06 2009-02-05 V Vente

Baker Bros. Capital (GP), LLC

Large shareholder
55 -2.8%
8,16
449 USD 		55 -2.8% 8,16 449 USD
2009-02-06 2009-02-05 V Vente

Baker / Tisch Capital (GP), LLC

Large shareholder
1 782 -2.1%
8,11
14 444 USD 		1 782 -2.1% 8,11 14 444 USD
2009-02-06 2009-02-05 V Vente

Baker / Tisch Capital (GP), LLC

Large shareholder
453 -0.5%
8,17
3 702 USD 		453 -0.5% 8,17 3 702 USD
2009-02-06 2009-02-05 V Vente

Baker / Tisch Capital (GP), LLC

Large shareholder
2 411 -2.8%
8,16
19 682 USD 		2 411 -2.8% 8,16 19 682 USD
2009-02-06 2009-02-05 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
142 827 -2.1%
8,11
1 157 713 USD 		142 827 -2.1% 8,11 1 157 713 USD
2009-02-06 2009-02-05 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
36 286 -0.5%
8,17
296 504 USD 		36 286 -0.5% 8,17 296 504 USD
2009-02-06 2009-02-05 V Vente

Baker Brothers Life Sciences Capital (GP), LLC

Large shareholder
193 252 -2.8%
8,16
1 577 574 USD 		193 252 -2.8% 8,16 1 577 574 USD
2009-02-06 2009-02-04 V Vente

14159 capital (GP), LLC

Large shareholder
24 256 -9.6%
8,46
205 191 USD 		24 256 -9.6% 8,46 205 191 USD
2009-02-06 2009-02-04 V Vente

14159 capital (GP), LLC

Large shareholder
2 593 -1.0%
8,47
21 961 USD 		2 593 -1.0% 8,47 21 961 USD
2009-02-06 2009-02-04 V Vente

14159 capital (GP), LLC

Large shareholder
269 -0.1%
9,03
2 430 USD 		269 -0.1% 9,03 2 430 USD
2009-02-06 2009-02-04 V Vente

BAKER JULIAN

Large shareholder
688 -9.6%
8,46
5 820 USD 		688 -9.6% 8,46 5 820 USD
2009-02-06 2009-02-04 V Vente

BAKER JULIAN

Large shareholder
74 -1.0%
8,47
627 USD 		74 -1.0% 8,47 627 USD
2009-02-06 2009-02-04 V Vente

BAKER JULIAN

Large shareholder
8 -0.1%
9,03
72 USD 		8 -0.1% 9,03 72 USD
2009-02-06 2009-02-04 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
256 936 -9.6%
8,46
2 173 524 USD 		256 936 -9.6% 8,46 2 173 524 USD
2009-02-06 2009-02-04 V Vente

Baker Biotech Capital (GP), LLC

Large shareholder
27 485 -1.1%
8,47
232 781 USD 		27 485 -1.1% 8,47 232 781 USD